Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

Latest news from Datamonitor

November 17, 2008 Sales and Marketing biosimilars, generics

Key decision makers will shape the biosimilars landscapeWith many biologic drugs used to treat increasingly common diseases such as cancer …
News

Roche strikes deal over Tarceva price

November 17, 2008 Sales and Marketing Roche, Taxotere

NICE is set to recommend Roche's lung cancer treatment Tarceva after the company agreed to lower the drug's price. The …
News

Government signs up supermarkets to help tackle obesity

November 14, 2008 Sales and Marketing NHS, obesity

More exercise and healthier eating are at the core of the government's new anti-obesity initiative, called Change4Life. Billed this week …
News

Crestor study has ‘profound implications’ for NICE guidance

November 14, 2008 Sales and Marketing Crestor, cv, lipid

AstraZeneca's statin Crestor made national headlines this week when it was shown to dramatically reduce major cardiovascular events. New data …
News

GSK delays US filing of Solzira

November 14, 2008 Sales and Marketing GSK, restless legs

GlaxoSmithKline has withdrawn the US application for its restless legs syndrome treatment Solzira. The company, along with co-developer XenoPort, is …
News

UK set for new flexible drug pricing, says Johnson

November 14, 2008 Sales and Marketing NHS, par

The government is working with the pharma industry on new 'flexible pricing' arrangements, even though revisions to the existing PPRS …
News

Good Publication Practice 2: updating best practice

November 13, 2008 Research and Development, Sales and Marketing GPP, Good Publication Practice, clinical trials, ethics, journals, publication

 Results from clinical trials are the very lifeblood of the pharmaceutical industry, representing the frontline in the search for new …
Feature

Government delays PPRS to maximise savings

November 12, 2008 Sales and Marketing ABPI, par

The PPRS deal agreed in principle this summer has been now thrown into confusion by government, with its launch at …
News

Amgen talks up blockbuster prospects

November 12, 2008 Research and Development, Sales and Marketing Amgen

Amgen says two of its pipeline products are potential blockbusters in three indications. The company is keen to reaffirm its …
News

US survey highlights co-payment worries

November 11, 2008 Sales and Marketing US, hc, reform

A US survey has shown that concern about the high cost of medicines means that many patients are not taking …
News

Pharma and NICE must end games of ‘one-upmanship’

November 10, 2008 Sales and Marketing NHS, par

Patient groups are calling on a pharmaceutical company to reach a compromise with NICE over a bone marrow cancer drug. …
News

Working Life: Viggo Birch

November 10, 2008 Business Services, Research and Development, Sales and Marketing Novo Nordisk, WL, careers

How did you arrive at your current position?A long story. I started in Mobil Oil in Denmark after graduating from …
Feature

Latest news from Datamonitor

November 10, 2008 Research and Development, Sales and Marketing HRT

Is there an alternative to HRT for menopausal relief?Sales of hormone replacement therapy have declined recently due to safety concerns, …
News

Emerging markets shine for AstraZeneca

November 6, 2008 Sales and Marketing AZ, China, hc

AstraZeneca saw overall sales for the three months to September rise 3% to $7.8 billion. But growth in emerging markets …
News

Major economies facing recession

November 6, 2008 Sales and Marketing hc

The UK, US and Japan must brace themselves for a full year of recession in 2009, according to economists. The …
News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 3, 2026

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026